Szela Mary T bought TLSI
February 13, 2024 · Form 4 insider transaction
Szela Mary T bought 125,000 shares of TriSalus Life Sciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 651 days after the transaction.
Direction
Acquired (buy-side)
Shares
125,000
Price
$0.00
Total value
N/A
InsiderSzela Mary T
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 13, 2024
Filing dateNovember 25, 2025
Shares owned after317,802
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the granting of Performance Stock Units (PSUs) upon achieving or exceeding $50 million of revenue over any 12 consecutive calendar month period ending on or before February 28, 2027. The PSUs vest immediately upon achieving the performance requirement, subject to the continued employment through each respective vesting date.